Advancing lab access to lyophilized bead technology

Hear from Brian Kirk, VP of Product Development, as he discusses BioDot’s mission and the growing role of microfluidics in the lab. Learn why lyophilized beads are gaining traction in diagnostics and pharma, and how the Sphera™ Discovery is set to bring lyobead production from larger manufacturing into the lab. Kirk also shares his vision for the future impact of lyobead technology on these industries.

This video was filmed at SLAS 2025.